Literature DB >> 11485832

Association of maspin expression with the malignancy grade and tumor vascularization in breast cancer tissues.

T Hojo1, Y Akiyama, K Nagasaki, K Maruyama, K Kikuchi, T Ikeda, M Kitajima, K Yamaguchi.   

Abstract

Maspin belongs to a tumor suppressing protein which is usually expressed highly in myoepithelial cells, and is significantly downregulated in breast cancer cells. We focused on identifying the correlation between maspin expression and the clinicopathological features of human breast cancer tissues using immunohistochemistry. There was a significant correlation in that maspin-positive tumor specimens showed a low pathological grade of malignancy, such as a lower infiltration of the tumor into the surrounding tissue and a downregulation of c-erbB2 expression. Moreover, maspin-positive cases showed a significant decrease in tumor vessels positively stained with anti-factor VIII-related antigen antibody. These results suggest that maspin production in myoepithelial cells could downregulate the malignant phenotype of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11485832     DOI: 10.1016/s0304-3835(01)00569-9

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  14 in total

1.  Simultaneous evaluation of maspin and CXCR4 in patients with breast cancer.

Authors:  Efthimia Tsoli; Petros K Tsantoulis; Alexandros Papalambros; Branko Perunovic; David England; David A Rawlands; Gary M Reynolds; Dimitrios Vlachodimitropoulos; Susan L Morgan; Chara A Spiliopoulou; Thanos Athanasiou; Vassilis G Gorgoulis
Journal:  J Clin Pathol       Date:  2006-06-02       Impact factor: 3.411

2.  Maspin Gene Expression in Invasive Ductal Carcinoma of Breast.

Authors:  Shahriar Dabiri; Mohammadmehdi Moeini Aghtaei; Jahanbano Shahryari; Manzume Shamis Meymandi; Sahar Amirpour-Rostami; Reza Foutohi Ardekani
Journal:  Iran J Pathol       Date:  2016

3.  Src phosphorylation converts Mdm2 from a ubiquitinating to a neddylating E3 ligase.

Authors:  Christopher N Batuello; Paula M Hauck; Jaimie M Gendron; Jason A Lehman; Lindsey D Mayo
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-26       Impact factor: 11.205

4.  Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer.

Authors:  Matthias Woenckhaus; Lukas Bubendorf; Peter Dalquen; Julia Foerster; Hagen Blaszyk; Martina Mirlacher; Markus Soler; Wolfgang Dietmaier; Guido Sauter; Arndt Hartmann; Peter J Wild
Journal:  J Clin Pathol       Date:  2006-05-12       Impact factor: 3.411

5.  Maspin expression in carcinoma ex pleomorphic adenoma.

Authors:  M T Martins; A Altemani; L Freitas; V C Araújo
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

6.  Clinicopathological significance of maspin expression in breast cancer.

Authors:  Mi Ja Lee; Chae Hong Suh; Zhu-Hu Li
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

7.  The role of insulin dependent NO synthesis in the impaired production of maspin in human breast cancer.

Authors:  G V Girish; G Bhattacharya; A Kumar Sinha
Journal:  J Cancer Res Clin Oncol       Date:  2006-02-21       Impact factor: 4.553

8.  The Role of Neutrophil Estrogen Receptor Status on Maspin Synthesis via Nitric Oxide Production in Human Breast Cancer.

Authors:  Karabi Ganguly Bhattacharjee; Mau Bhattacharyya; Umesh Chandra Halder; Pradipta Jana; Asru K Sinha
Journal:  J Breast Cancer       Date:  2012-06-28       Impact factor: 3.588

9.  The "Cross Talk" between the Receptors of Insulin, Estrogen and Progesterone in Neutrophils in the Synthesis of Maspin through Nitric Oxide in Breast Cancer.

Authors:  Karabi Ganguly Bhattacharjee; Mau Bhattacharyya; Umesh Chandra Halder; Pradipta Jana; Asru K Sinha
Journal:  Int J Biomed Sci       Date:  2012-06

10.  Role of maspin in cancer.

Authors:  Rossana Berardi; Francesca Morgese; Azzurra Onofri; Paola Mazzanti; Mirco Pistelli; Zelmira Ballatore; Agnese Savini; Mariagrazia De Lisa; Miriam Caramanti; Silvia Rinaldi; Silvia Pagliaretta; Matteo Santoni; Chiara Pierantoni; Stefano Cascinu
Journal:  Clin Transl Med       Date:  2013-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.